Browse > Article
http://dx.doi.org/10.3345/kjp.2008.51.11.1211

Diamond-Blackfan anemia: long-term follow-up of six cases  

Son, Young Jun (St. Carollos Hospital)
Baek, Hee Jo (Department of Pediatrics, Chonnam National University Hwasun Hospital, Chonnam National University Medical School)
Kook, Hoon (Department of Pediatrics, Chonnam National University Hwasun Hospital, Chonnam National University Medical School)
Publication Information
Clinical and Experimental Pediatrics / v.51, no.11, 2008 , pp. 1211-1216 More about this Journal
Abstract
Purpose : Diamond-Blackfan anemia (DBA) is a rare heterogeneous genetic disorder of infancy and early childhood. It is characterized by red cell aplasia, congenital anomalies, and a predisposition to cancer. Corticosteroids and red cell transfusions are the mainstays of therapy. We describe our experience of 6 cases of DBA that were encountered over a period of 16 years. Methods : Medical records of 6 patients diagnosed to have DBA and admitted to the Chonnam National University Hospital between 1992 and 2008 were retrospectively reviewed. Results : Three patients were males. The age at diagnosis ranged from 3 to 18 months (median, 5.5 months). Heart defects were observed in 4, polydactyly in 2, and strabismus in 1 patient. The median number of transfusions was 3 (range, 2-8). All patients responded to initial treatment with steroids and had a hemoglobin level ${\geq}9g/dL$ with a median of 12.5 days (range, 7-22 days). Three patients are currently not receiving steroid therapy. A minimum dose of oral prednisolone (<5 mg per day) was required to maintain hemoglobin ${\geq}9mg/dL$ in 3 cases. Red cell transfusion was infrequently required in 1 patient. In the median follow-up of 14 years, there was no development of malignancy. No significant side effects of steroids were found, except for short stature in 2. Conclusion : The majority of DBA patients achieved complete response and under maintenance therapy with low dose of steroids. Close observation is needed to monitor steroid side effects, cardiac function, and development of malignancy. A nation-wide survey is necessary to further characterize this rare disease in Korean children.
Keywords
Diamond-Blackfan anemia; Steroid treatment;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Diamond LK, Blackfan KD. Hypoplastic anemia. Am J Dis Child 1938; 56:464-7
2 Orfali KA, Ohene-Abuakwa Y, Ball SE. Diamond Blackfan anaemia in the UK: Clinical and genetic heterogeneity. Br J Haematol 2004;125:243-52   DOI   ScienceOn
3 Gazda H, Lipton JM, Willig TN, Ball S, Niemeyer CM, Tchernia G, et al. Evidence for linkage of familial Diamond- Blackfan anemia to chromosome 8p23.3-p22 and for non-19q non-8p disease. Blood 2001;97:2145-50   DOI   ScienceOn
4 Bernini JC, Carrillo JM, Buchanan GR. High-dose intravenous methylprednisolone therapy for patients with Diamond- Blackfan anemia refractory to conventional doses of prednisone. J Pediatr 1995;127:654-9   DOI   ScienceOn
5 Alessandri AJ, Rogers PC, Wadsworth LD, Davis JH. Diamond- Blackfan anemia and cyclosporine therapy revisited. J Pediatr Hematol Oncol 2000;22:176-9   DOI   ScienceOn
6 Lee JM, Kim HJ. A case of congenital pure red cell anemia. Korean J Clin Pathol 1994;14:135-41
7 Lanzkowsky P. Manual of pediatric hematology and oncology. 4th ed. Elsevier academic press, 2005:94-9
8 Lipton JM, Atisidafos E, Zyskind I, Vlachos A. Improving clinical care and elucidating the pathophysiology of Diamond- Blackfan anemia: an update from the Diamond-Blackfan anemia registry. Pediatr Blood Cancer 2006;46:558-64   DOI   ScienceOn
9 Chen S, Warszawski J, Bader-Meunier B, Tchernia G, Da Costa L, Marie I, et al. Diamond-Blackfan anemia and growth status: the French registry. J Pediatr 2005;147:669-73   DOI   ScienceOn
10 Willig TN, Perignon JL, Gustavsson P, Gane P, Draptchinskaya N, Testard H, et al. High adenosine deaminase level among healthy probands of Diamond Blackfan anemia (DBA) cosegregates with the DBA gene region on chromosome 19q13. Blood 1999;92:4422-7
11 Buitendag DJ. Pure red-cell aplasia associated with carbamazepine. A case report. S Afr Med J 1990;78:214-5
12 Alter BP, Bonno M, Azuma E. Correspondence: bone marrow transplant in Diamond-Blackfan Anemia. Bone Marrow Transplant 1998;21:965-7
13 Fisch P, Handgretinger R, Schaefer HE. Pure red cell aplasia. Br J Haematol 2000;111:1010-22   DOI   ScienceOn
14 Da Costa L, Willig TN, Fixler J, Mohandas N, Tchernia G. Diamond-Blackfan anemia. Curr Opin Pediatr 2001;13:10-5   DOI   ScienceOn
15 Whitehouse DB, Hopkinson DA, Pilz AJ, Arredondo FXl. Adenosine deaminase activity in a series of 19 patients with the Diamond-Blackfan syndrome. Acta Exp Med Biol 1986; 195:85-92
16 Cmejla R, Cmejlova J, Handrkova H, Petrak J, Pospisilova D. Ribosomal Protein S17 Gene (RPS17) is mutated in Diamond-Blackfan Anemia. Hum Mutat 2007;28:1178-82   DOI   ScienceOn
17 Ohence-Abuakwa Y, Orfali KA, Marius C, Ball SE. Twophase culture in Diamond-Blackfan anemia: Localization of erythroid defect. Blood 2005;105:838-46   DOI   ScienceOn
18 Vettenranta K, Saarinen UM. Cord blood stem cell transplantation for Diamond-Blackfan anemia. Bone Marrow Transplant 1997;19:507-8   DOI
19 Kim GP, Lee KS, Cha SD, Lee DB, Kim SM, Lee CM. A case report of congenital pure red cell anemia. Korean J Hematol 1976;11:39-45
20 Perdahl EB, Naprstek BL, Wallace WC, Lipton JM. Erythroid failure in Diamond-Blackfan anemia is characterized by apoptosis. Blood 1994;83:645-50
21 Diamond LK, Wang WC, Alter BP. Congenital hypoplastic anemia. Adv Pediatr 1976;22;349-78
22 Sin SH, Choi Y, Im IS, Kim CH, You CH. A case of congenital pure red cell anemia. Res Med Sci (Korea) 1993;25: 151-5
23 Josephs HW. Anaemia of infancy and early childhood. Medicine 1936;15:307-451   DOI
24 Willig TN, Gazda H, Sieff CA. Diamond-Blackfan anemia. Curr Opin Hematol 2000;7:85-94   DOI   ScienceOn
25 EL-Beshlawy A, Ibrahim IY, Rizk S, Eid K. Study of 22 Egyptian patients with Diamond-Blackfan anemia, corticosteroids and cyclosporine therapy results. Pediatrics 2002; 110:1-5   DOI   ScienceOn
26 Vlachos A. Federman N, Reyes-Haley C, Abramson J, Lipton JM. Hematopoietic stem cell transplantation for Diamond Blackfan anemia: A report from the Diamond Blackfan anemia Registry. Bone Marrow Transplant 2001;27:381-6   DOI
27 Splain J, Berman BW. Cyclosporine A treatment for Diamond- Blackfan anemia. Am J Hematol 1992;39:208-11   DOI   ScienceOn
28 Alter BP. Inherited bone marrow failure syndromes. In: Nathan DG, Orkin SH, Ginsburg D, Look AT, editors, Hematology of Infancy and Childhood, 6th ed. Philadelphia: WB Saunders Co, 2003;318-31
29 Willig TN, Niemeyer CM, Leblanc T, Tiemann C, Robert A, Budde J, et al. Identification of new prognosis factors from the clinical and epidemiology analysis of a registry of 229 Diamond-Blackfan anemia patients. Pediatr Res 1999;46: 553-61   DOI   ScienceOn
30 Becker RE, Maurer H, Bowyer FP. Growth hormone deficiency in Diamond Blackfan anemia. Pediatr Res 1991;29:74a
31 Gillio AP, Faulkner LB, Alter BP, Reilly L, Klafter R, Heller G, et al. Treatment of Diamond-Blackfan anemia with recombinant human interleukin-3. Blood 1993;82:744-51
32 Scott EG, Haider A, Hord J. Growth hormone therapy for short stature in Diamond Blackfan anemia. Pediatr Blood Cancer 2004;43:542-4
33 Gazda HT, Grabowska A, Merida-Long LB, Latawiec E, Schneider HE, Lipton JM et al. Ribosomal protein S24 gene is mutated in Diamond-Blackfan anaemia. Am J Hum Genet 2006;79:1110-8   DOI   ScienceOn
34 Lenarsky C, Weinberg K, Guinan E, Dukes PP, Barak Y, Ortega J, et al, Bone marrow transplantation for constitutional pure red cell aplasia. Blood 1988;71:226-9
35 Glader BE, Backer K. Comparative activity of erythrocyte adenosine deaminase and orotidine decarboxylase in Diamond- Blackfan anemia. Am J Hematol 1986;23:135-9   DOI   ScienceOn
36 Tagawa T, Sumi K, Uno R, Itagaki Y. Fujii F, Yamaguchi H. Pure red cell aplasia during carbamazepine monothrerapy. Brain Dev 1997;19:300-2   DOI   ScienceOn